Khan MA - Search Results

1

Oleuropein: A natural antioxidant molecule in the treatment of metabolic syndrome.

Ahamad J, Toufeeq I, Khan MA, Ameen MSM, Anwer ET, Uthirapathy S, Mir SR, Ahmad J. Ahamad J, et al. Among authors: khan ma. Phytother Res. 2019 Dec;33(12):3112-3128. doi: 10.1002/ptr.6511. Epub 2019 Nov 20. Phytother Res. 2019. PMID: 31746508 Review.

2

Nanotechnology Based Theranostic Approaches in Alzheimer's Disease Management: Current Status and Future Perspective.

Ahmad J, Akhter S, Rizwanullah M, Khan MA, Pigeon L, Addo RT, Greig NH, Midoux P, Pichon C, Kamal MA. Ahmad J, et al. Among authors: khan ma. Curr Alzheimer Res. 2017;14(11):1164-1181. doi: 10.2174/1567205014666170508121031. Curr Alzheimer Res. 2017. PMID: 28482786 Free PMC article. Review.

3

Insights into the Targeting Potential of Thymoquinone for Therapeutic Intervention Against Triple-negative Breast Cancer.

Barkat MA, Harshita, Ahmad J, Khan MA, Beg S, Ahmad FJ. Barkat MA, et al. Among authors: khan ma. Curr Drug Targets. 2018;19(1):70-80. doi: 10.2174/1389450118666170612095959. Curr Drug Targets. 2018. PMID: 28606050 Review.

4

PI3K/AKT/mTOR pathway inhibitors in triple-negative breast cancer: a review on drug discovery and future challenges.

Khan MA, Jain VK, Rizwanullah M, Ahmad J, Jain K. Khan MA, et al. Drug Discov Today. 2019 Nov;24(11):2181-2191. doi: 10.1016/j.drudis.2019.09.001. Epub 2019 Sep 11. Drug Discov Today. 2019. PMID: 31520748 Review.

5

Effect of Nardostachys jatamansi DC. on Apoptosis, Inflammation and Oxidative Stress Induced by Doxorubicin in Wistar Rats.

Singh M, Khan MA, Y T K, Ahmad J, Fahmy UA, Kotta S, Alhakamy NA, Ahmad S. Singh M, et al. Among authors: khan ma. Plants (Basel). 2020 Nov 15;9(11):1579. doi: 10.3390/plants9111579. Plants (Basel). 2020. PMID: 33203171 Free PMC article.

6

Recent Advances in Theranostic Applications of Nanomaterials in Cancer.

Ahmed F, Khan MA, Haider N, Ahmad MZ, Ahmad J. Ahmed F, et al. Among authors: khan ma. Curr Pharm Des. 2022;28(2):133-150. doi: 10.2174/1381612827666210916140627. Curr Pharm Des. 2022. PMID: 34530703

7

Novel therapeutic interventions for combating Parkinson's disease and prospects of Nose-to-Brain drug delivery.

Ahmad J, Haider N, Khan MA, Md S, Alhakamy NA, Ghoneim MM, Alshehri S, Sarim Imam S, Ahmad MZ, Mishra A. Ahmad J, et al. Among authors: khan ma. Biochem Pharmacol. 2022 Jan;195:114849. doi: 10.1016/j.bcp.2021.114849. Epub 2021 Nov 19. Biochem Pharmacol. 2022. PMID: 34808125 Review.

8

Immunology of osteoporosis: relevance of inflammatory targets for the development of novel interventions.

Ahmad SS, Ahmed F, Ali R, Ghoneim MM, Alshehri S, Najmi AK, Ahmad S, Ahmad MZ, Ahmad J, Khan MA. Ahmad SS, et al. Among authors: khan ma. Immunotherapy. 2022 Jul;14(10):815-831. doi: 10.2217/imt-2021-0282. Epub 2022 Jun 29. Immunotherapy. 2022. PMID: 35765988 Review.

9

Receptor-Targeted Surface-Engineered Nanomaterials for Breast Cancer Imaging and Theranostic Applications.

Ahmad J, Rizwanullah M, Suthar T, Albarqi HA, Ahmad MZ, Vuddanda PR, Khan MA, Jain K. Ahmad J, et al. Among authors: khan ma. Crit Rev Ther Drug Carrier Syst. 2022;39(6):1-44. doi: 10.1615/CritRevTherDrugCarrierSyst.2022040686. Crit Rev Ther Drug Carrier Syst. 2022. PMID: 35997100

10

Utilization of Nanotechnology to Improve Bone Health in Osteoporosis Exploiting Nigella sativa and Its Active Constituent Thymoquinone.

Ahmad J, Albarqi HA, Ahmad MZ, Orabi MAA, Md S, Bandopadhyay R, Ahmed F, Khan MA, Ahamad J, Mishra A. Ahmad J, et al. Among authors: khan ma. Bioengineering (Basel). 2022 Nov 1;9(11):631. doi: 10.3390/bioengineering9110631. Bioengineering (Basel). 2022. PMID: 36354542 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,827 results

Search Page

Filters